SCHEMBL5223388

SCHEMBL5223388

CCNC1C(=O)N(c2cccc(C(=O)OC)c2)CC1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.51
GAA P10253 1/20 0.50
CACNA2D1 P54289 1/20 0.43
ALDH1A1 P00352 3/20 0.43
ATM Q13315 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
CTSG P08311 1/20 0.42
CMA1 P23946 1/20 0.42
TP53 P04637 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
HPGD P15428 3/20 0.41
PMM2 O15305 1/20 0.41
MPI P34949 1/20 0.41
RAB9A P51151 1/20 0.41
PHOSPHO1 Q8TCT1 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218300 0.88 GRM2 (0.50) GRM2GAACACNA2D1ALDH1A1ATM
SCHEMBL5219621 0.81 GAA (0.54) GRM2GAAALDH1A1ATMLMNA
SCHEMBL5226071 0.78 GAA (0.51) GRM2GAAALDH1A1ATMLMNA
SCHEMBL2623576 0.77 GAA (0.55) GRM2GAAALDH1A1ATMLMNA
SCHEMBL2623592 0.77 GAA (0.55) GRM2GAAALDH1A1ATMLMNA
SCHEMBL4121023 0.77 GAA (0.57) GRM2GAAALDH1A1ATMLMNA
SCHEMBL5219880 0.73 GAA (0.53) GRM2GAAALDH1A1LMNAMAPK1
SCHEMBL6568249 0.71 GAA (0.56) GRM2GAACACNA2D1ALDH1A1ATM
SCHEMBL28758908 0.70 GAA (0.55) GRM2GAAALDH1A1ATMLMNA
SCHEMBL8090375 0.70 GAA (0.55) GRM2GAAALDH1A1ATMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed